Background: TAO is seen in about 80% of patients with Graves' disease; it may also occur in patients with thyroid cancers or autoimmune hypothyroid due to Hashimoto's thyroiditis in about 10% of TAO, while individuals with no thyroid disease were found to have orbital lesions in 10 percent of total cases. A 46-year- Case presentation: old male patient who is a known case of hypertension and hypothyroidism attended to medical OPD of SVS Hospital with foreign body sensation in both eyes, bulging of eyeballs and excessive watering in both eyes. He was on 40 mg of telmisartan and 50 micrograms of thyroxine daily for about 6 months. Pulse was 56 per minute and a blood pressure of 146/96 mmHg. The patient was treated with methyl prednisolone initially weekly intravenous doses followed by oral medication along with increased levothyroxine to 150 micrograms, selenium and statins. He was symptomatically better after 6 weeks of therapy. Summary and conclusion: Hypothyroid grave disease is very rare that too in a male patient. Treatment does not differ from Hyperthyroid Graves' disease except the supplementation of levothyroxine instead of anti-thyroid measures. The literature has been reviewed.
Background: Hyperosmolar hyperglycemic state (HHS) is one of two serious metabolic derangements that occur in patients with diabetes mellitus (DM). Hyperosmolar hyperglycemic state can lead to hyper viscosity which can be considered as a cause for cerebral vascular accident. We present a case of stroke mimic presenting rst time with hyperglycemia and hyperosmolarity. Hyperosmolar hyperglycemic state (HHS) is one of two serious metabolic derangements that occur in patients with diabetes mellitus (DM). Hyperosmolar hyperglycemic state can lead to hyper viscosity which can be considered as a cause for cerebral vascular accident. A case of stroke mimic presenting rst time with hyperglycemia and hyperosmolarity. Relevant history from literature has been presented
BACKGROUND: Cerebral venous and sinus thrombosis is not a rare disease in India and abroad. The present study was undertaken to various clinical and radiological manifestations of the same. METHODS AND MATERIALS: A total 100 patients admitted to SVS Medical college and hospital, Mahabubnagar between September 2013 to September 2020 with a conrmed diagnosis of cerebral venous thrombosis were studied in this study. Detailed clinical examination along with basic investigations including CT/MRI brain and MRV/CTV in all. RESULTS: Headache and seizures are the most common ndings followed by paresis and fever. Alcohol addiction and tobacco consumption were found to be present in 53 and 56% of cases followed by iron deciency in 45, hypertension in 35, pregnancy related cases were only 18. Steroid abuse and hypothyroidism were noted in 18 and 16 instances while evidence of infection was noted in a dozen patients. Cerebral imaging (CT/MRI) revealed venous infarction hemorrhagic or non-hemorrhagic in 67 patients and isolated CVT without infarction in 21 patients. Infarctions were unilateral in 56 patients. Superior Sagittal Sinus in combination with other deep venous sinuses was seen in 54 percent of this study. CONCLUSION: CVST presents in young and equal in frequency in males and females. Headache, seizures are more frequent symptoms. Addiction with alcohol and tobacco are the more frequent risk factors followed by Iron deciency anemia and hypertension. SSS was the most common site of venous sinus thrombosis.
Portal vein thrombosis (PVT) is rare in pregnancy . The most common underlying causes are abdominal trauma, pancreatitis, myeloproliferative disorders, and hereditary deciency of natural 2,3,4 anticoagulants (protein C, S and anti-thrombin III) . We report a case of acute PVT in a pregnant woman with no history of thrombosis or evidence of coagulation disorder or thrombophilia who had infection with SARS-CoV-2 (COVID 19).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.